Paralel Advisors LLC Takes $2.50 Million Position in HealthEquity, Inc. $HQY

Key Points

• Paralel Advisors initiated a $2.50 million position in HealthEquity during the second quarter by purchasing 27,661 shares. Institutional investors collectively own 99.55% of the company.
• HealthEquity exceeded quarterly expectations, reporting $1.24 in earnings per share versus the $1.11 consensus estimate and $354.64 million in revenue. Revenue increased 7.2% year over year, while the company provided fiscal 2027 EPS guidance of $2.88–$2.95.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $110.93, compared with the stock’s reported $104.27 opening price. Insiders sold 17,905 shares worth approximately $1.65 million over the last quarter.

Paralel Advisors LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 27,661 shares of the company's stock, valued at approximately $2,498,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity during the 4th quarter worth about $27,000. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity in the 4th quarter valued at about $28,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company's stock valued at $28,000 after purchasing an additional 293 shares during the period. Leonteq Securities AG boosted its position in shares of HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company's stock valued at $32,000 after purchasing an additional 235 shares in the last quarter. Finally, Silvant Capital Management LLC acquired a new stake in HealthEquity during the second quarter worth approximately $35,000. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Stock Performance

Shares of HQY opened at $104.27 on Friday. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62. The company has a market cap of $8.72 billion, a PE ratio of 39.05, a P/E/G ratio of 1.75 and a beta of 0.21. The stock has a 50-day moving average of $96.30 and a 200-day moving average of $87.07. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity's revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Insider Activity

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of HealthEquity stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the sale, the executive vice president directly owned 52,244 shares of the company's stock, valued at approximately $4,963,180. The trade was a 4.31% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock worth $1,651,280 over the last quarter. 1.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on HQY. Wells Fargo & Company set a $111.00 target price on HealthEquity in a report on Monday, June 1st. BTIG Research increased their price target on HealthEquity from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Friday, July 24th. Wall Street Zen downgraded shares of HealthEquity from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Weiss Ratings upgraded shares of HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a research note on Friday, June 5th. Finally, Royal Bank Of Canada boosted their target price on shares of HealthEquity from $100.00 to $108.00 and gave the company an "outperform" rating in a research report on Wednesday, June 3rd. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, HealthEquity presently has a consensus rating of "Moderate Buy" and an average price target of $110.93.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source